Navigation Links
Developing Robust Potency Assays for Validation, New Webinar hosted by Xtalks

Toronto, Canada (PRWEB) January 30, 2013

Cell-based assays, or bioassays, are important for establishing safety, efficacy and stability profiles biopharmaceuticals. What’s more, these assays must be sufficiently robust to meet international regulatory and USP guidelines for system suitability. These tools are crucial for drug product lot release and stability testing to support licensing for commercialization.

Generally, assays are designed to demonstrate the relative potency of a product by comparing the biological response with a control preparation (such as USP, WHO, or an in-house reference standard). These assays are an essential component of the characterization/validation process and can be used to select candidates; establish comparability; test process intermediates, formulations and stability/degradation; and to support product changes.

In this webinar, our expert, Dr. Peter Wunderli, will review a case study for a biological drug product. Dr. Wunderli will go over topics including: the re-development of the bioassay method for potency and an improved process for extracting the drug product from a carrier so that the potency of the final drug product could be reproducibly measured.

For more information about this event or to register, visit:

Xtalks is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit

Karen Lim (416) 977-6555 ext 227

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Gated STED -- developing the next generation of super-resolution microscopes
2. Elsevier Foundation Awards 2011 Grants to Advance Women in Science and Support Libraries in Developing Countries
3. Frost & Sullivan Recognizes iCubate for Developing the New Gold Standard Instrument in the PCR Market
4. CNIO researchers describe a new target for developing anti-angiogenic and anti-tumoral therapies
5. SRI International Researchers Developing Bioadhesive Gel to Protect Women from HIV and HSV Infections
6. Carnegie Mellons Jeffrey Hollinger Leads Research Team Developing New Tools To Ease Pain of Combat Injuries
7. Elsevier Offers Entire Collection of Journals and Books to Innovators in Developing Countries Through the Access to Research for Development and Innovation (ARDI) Program
8. Phalanx Biotech Group Reports Robust Revenue Growth in 2011
9. endpoint Adopts New Technology To Boast Most Robust IVR Validation Objective Evidence and Decrease IVR Build Timelines
10. New nanotech fiber: Robust handling, shocking performance
11. Life Technologies Partners With DaAn Gene to Develop and Commercialize Molecular Diagnostic Assays in China
Post Your Comments:
(Date:12/1/2015)... Dec. 1, 2015  CardioCell LLC, a Stemedica ... cells for cardiovascular indications, intends to proceed with ... on recommendations from a Heart Failure Advisory Board ... Scientific Advisory Board members . In a recent ... IIa safety and efficacy data from CardioCell,s on-going ...
(Date:12/1/2015)... Cepheid (Nasdaq: CPHD ) today announced ... Jaffray Healthcare Conference in New York City ... its outlook for the fourth quarter of 2015 and ... longer term business model expectations. John Bishop ... to be the fastest growing company of the major ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... physicians, aesthetic practitioners and aesthetics professionals from Central America and abroad for the ... in Panama City, Panama Feb. 17-19, 2016. Testart will present and discuss new ...
(Date:11/30/2015)... , Dec. 1, 2015 /PRNewswire/ - BioAmber Inc. (NYSE: ... it has joined the American Business Act on Climate Pledge, ... that are standing with the Obama Administration to demonstrate an ... a strong outcome to the COP21 Paris ... --> Sarnia, Canada . --> ...
Breaking Biology Technology:
(Date:11/2/2015)... 2015  SRI International has been awarded a contract ... services to the National Cancer Institute (NCI) PREVENT Cancer ... expertise, modern testing and support facilities, and analytical instrumentation ... toxicology studies to evaluate potential cancer prevention drugs. ... Cancer Drug Development Program is an NCI-supported pipeline to ...
(Date:10/29/2015)... health pioneer, Joseph C. Kvedar , MD, describes ... wellness, and the business opportunities that arise from it ... Healthy Things . Long before health and wellness ... vice president, Connected Health, Partners HealthCare, was creating a ... the hospital or doctor,s office into the day-to-day lives ...
(Date:10/27/2015)... SAN JOSE, Calif. , Oct. 27, 2015 /PRNewswire/ ... human interface solutions, today announced that Google has adopted ... family of touch controller solutions to power its newest ... Nexus 6P by Huawei. --> ... ecosystem partners like Google to provide strategic collaboration in ...
Breaking Biology News(10 mins):